SV Life Sciences raising sixth fund, goal is $400 million

SV Life SciencesWith nearly $2 billion under management, SV Life Sciences has started raising its sixth fund with a target of $400 million. The group invests in biotechnology, medical devices, health IT, and healthcare services. Click here for more information on the latest effort.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.